SCHEMBL17653175

SCHEMBL17653175

COc1cc2nc(N(CCC(C)C)C(=O)OCc3ccccc3)[nH]c(=O)c2cc1C=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.43
AAK1 Q2M2I8 1/20 0.41
PDE3B Q13370 1/20 0.39
PDE3A Q14432 1/20 0.39
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
POLB P06746 1/20 0.37
TSHR P16473 1/20 0.37
TUBB4A P04350 1/20 0.37
TUBB P07437 1/20 0.37
TUBA3C P0DPH7 1/20 0.37
TUBA1B P68363 1/20 0.37
TUBA4A P68366 1/20 0.37
TUBB4B P68371 1/20 0.37
TUBB3 Q13509 1/20 0.37
TUBB2A Q13885 1/20 0.37
TUBB8 Q3ZCM7 1/20 0.37
TUBA3E Q6PEY2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17653150 0.93 AAK1 (0.49) KDM4EAAK1PDE3BPDE3AMEN1
SCHEMBL17653084 0.88 KDM4E (0.44) KDM4EAAK1PDE3BPDE3AMEN1
SCHEMBL17653196 0.87 AAK1 (0.39) KDM4EAAK1MEN1KMT2ASMN1; SMN2
SCHEMBL17653107 0.85 KDM4E (0.41) KDM4EAAK1PDE3BPDE3AMEN1
SCHEMBL17653349 0.84 AAK1 (0.45) KDM4EAAK1MEN1KMT2ASMN1; SMN2
SCHEMBL17653110 0.82 IMPDH2 (0.46) KDM4EAAK1
SCHEMBL17653141 0.82 AAK1 (0.38) KDM4EAAK1PDE3BPDE3AMEN1
SCHEMBL17653266 0.82 AAK1 (0.46) KDM4EAAK1MMP13
SCHEMBL17663478 0.75 AAK1 (0.69) AAK1MEN1KMT2ASMN1; SMN2POLB
SCHEMBL17653187 0.75 AAK1 (0.46) KDM4EAAK1MEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3200797-A1 QUINAZOLINE-BASED KINASE INHIBITORS Bristol-Myers Squibb Company (US) 2017-08-09 EP disclosed
WO-2016053794-A1 QUINAZOLINE-BASED KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2016-04-07 WO disclosed